NCSP Review

Part 4A Section 112O of the Health Act 1956 requires regular, independent reviews of the NCSP to be undertaken. The third such review took place in the second half of 2018.

The purpose of the review was to ensure the NCSP is of the highest possible quality, and continues to reduce rates of cervical cancer, and the number of women who die from it. 

The following Review Committee members were appointed by Cabinet: 

  • Ms Gail Ward (Chair), who offers expertise in cancer screening programme management
  • Professor Ian Hammond, who offers expertise in gynaecological oncology and implementation of HPV screening
  • Ms Liane Penney, who offers extensive experience in Māori health and equity research and evaluation. 

The review was completed in April 2019 and the Committee's report is available below, along with earlier reports.

In this section

Page last updated: 30 June 2015